DekaBank Deutsche Girozentrale - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 141 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$130,000
-27.8%
14,450
-2.7%
0.00%0.0%
Q3 2019$180,000
-36.4%
14,850
-50.0%
0.00%0.0%
Q2 2019$283,000
-36.4%
29,700
+63.6%
0.00%
-66.7%
Q1 2019$445,000
+96.0%
18,150
+22.2%
0.00%
+50.0%
Q4 2018$227,000
-49.0%
14,850
-18.2%
0.00%
-33.3%
Q3 2018$445,000
+17.7%
18,150
-2.7%
0.00%
+50.0%
Q2 2018$378,000
+12.2%
18,650
+2.8%
0.00%0.0%
Q1 2018$337,000
+3.7%
18,150
-2.7%
0.00%
-33.3%
Q4 2017$325,0000.0%18,6500.0%0.00%0.0%
Q3 2017$325,000
-4.4%
18,6500.0%0.00%0.0%
Q2 2017$340,000
-20.6%
18,6500.0%0.00%
-25.0%
Q1 2017$428,000
-38.5%
18,650
-7.4%
0.00%
-42.9%
Q4 2016$696,000
+55.0%
20,150
+8.0%
0.01%
+40.0%
Q3 2016$449,000
+0.9%
18,6500.0%0.01%0.0%
Q2 2016$445,000
+34.4%
18,650
+24.7%
0.01%
+25.0%
Q1 2016$331,000
-37.4%
14,950
-13.8%
0.00%
-33.3%
Q4 2015$529,000
-22.8%
17,350
+0.6%
0.01%
-25.0%
Q3 2015$685,000
-31.4%
17,248
+19.4%
0.01%
-33.3%
Q2 2015$998,000
+30.8%
14,450
+3.6%
0.01%
+20.0%
Q1 2015$763,000
+34.3%
13,950
+5.7%
0.01%
+42.9%
Q4 2014$568,000
+37.9%
13,200
+2.3%
0.01%
+16.7%
Q3 2014$412,000
+57.9%
12,900
+2.4%
0.01%
+50.0%
Q2 2014$261,0000.0%12,600
-6.7%
0.00%0.0%
Q1 2014$261,000
-8.7%
13,500
+8.9%
0.00%
-20.0%
Q4 2013$286,000
+10.0%
12,400
+2.5%
0.01%0.0%
Q3 2013$260,00012,1000.01%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Bleichroeder LP 1,299,994$12,220,0002.19%
Camber Capital Management LP 8,780,000$82,532,0002.18%
Palo Alto Investors LP 3,003,875$28,236,0001.55%
ARMISTICE CAPITAL, LLC 4,120,000$38,728,0001.40%
Permanens Capital L.P. 359,311$3,378,0001.17%
IRONWOOD INVESTMENT MANAGEMENT LLC 31,582$297,0000.21%
BOOTHBAY FUND MANAGEMENT, LLC 348,000$3,271,0000.20%
Teza Capital Management LLC 20,300$191,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 767,135$7,211,0000.08%
Livforsakringsbolaget Skandia, Omsesidigt 38,800$365,0000.04%
View complete list of AMAG PHARMACEUTICALS INC shareholders